Introduction
Epilepsy is a chronic condition with numerous social and psychological consequences. High prevalence of Seizure (2007) 
Summary
Objectives: To assess the influence of different factors on health-related QOL in adults with epilepsy in Moscow, Russia. Method: We evaluated quality of life in 242 patients (98 de novo and 144 previously inadequately treated) by using QOLIE-31. Partial cryptogenic or symptomatic epilepsy was diagnosed in 214 patients, in 28-idiopathic generalized epilepsy. Stepwise regression analysis was performed to assess the influence of different factors on QOL. Results: In patients with epilepsy in Russia the total score of QOLIE-31 was rather low--42.13 AE 4.14. Relationship of quality of life (total score) and frequency of seizures and duration of disease was analyzed. Frequency of seizures was the most significant parameter related to QOL (R = 0.46 with total score). Duration of disease also correlated with QOL score (R = 0.24 with total score). Significant but rather weak association (link) between frequency of seizures and almost all of subscales of quality of life was noticed. Duration of epilepsy correlated with less number of subscales: Energy/fatigue, Medication effects, Social functioning, Overall QOL subscales. When factors influencing on QOL were separately analyzed in newly diagnosed and previously treated patients frequency of seizures was the most important parameter in both groups. Conclusions: Frequency of seizures is the most important factor influencing on QOL in adults with epilepsy (newly diagnosed and previously treated). # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. epilepsy and stigmatization of patients cause high social significance of disease. 12, 22, 26 It is important that epilepsy is potentially curable and remission may be achieved in relatively large proportion of patients. 16 Brodie and Dichter 4 showed that seizures can be completely controlled in 60-70% of patients. Adequate therapy improves medical and social prognosis of patients, possibility of every individual to implement his or her abilities. As demonstrated by several studies, [28] [29] [30] quality of life (QOL) is worse in epileptic patients than in the general population. For instance, patients with epilepsy had significantly lower scores compared with healthy persons in six domains of the SF-36 in a prospective observational study of patients with partial or generalized epileptic seizures. 29 Several authors investigated the influence of different factors on quality of life. QOL of patients with epilepsy depended upon effectiveness of antiepileptic therapy and disease duration; QOL was poor in patients with partial seizures; the best QOL scores were found in patients who were free from seizures. 24, 27 Frequency of seizures seemed to be one of the most relevant determinants of poor quality-of-life scores. 13, 19 Being seizure free was a necessary but not sufficient condition to have a good quality of life. 2, 28 Still, HRQL scores for seizure-free patients were similar to the general population. 17 Overall, quality of life was worse in patients with epilepsy than in the general population; it was comparable or worse in patients with epilepsy than that in patients with other chronic conditions; and it was similar to that of healthy persons when patients with epilepsy are well-controlled. Depression contributed to the poor QOL in epilepsy 5, 8, 23 and was a powerful predictor of QOL in patients with farmacoresistant epilepsy. 3 These data were obtained mostly in the USA and Western Europe. Better understanding of QOL in people with epilepsy leaving in different countries is important: a large number of cultural, ethnic, economical differences have their impact on the QOL.
The aim of the present study was to identify main factors influencing on the HRQOL in the cohort of patients with epilepsy in Russia. Up to now there are no published papers about QOL in epilepsy patients in Russia in the literature in English.
Methods
Evaluation of 242 patients with epilepsy (age 15-59; 120 men and 122 women) in Moscow was performed. This group consisted of patients revealed in several neighboring regions of Moscow during epidemiology study. Patients revealed during the epidemiology study formed a substantial proportion (more than 70%) of patients included in this study. The epidemiology study in Moscow is a fragment of the Program of epidemiology study in Russia, performed during 5 years in different regions of the country. Within this study different methods of data collection have been used, including data collection from outpatient neurology and psychiatry departments, a record of emergency calls for seizures in the public places, interviews during the door-to-door studies. Patients revealed during this study were then investigated in the Department of Neurology and Neurosurgery of the Russian State Medical University. Another part of patients, included in this study, was referred to our department by local physicians (general practitioners, neurologists, psychiatrists, etc., without any specialization in epileptology) for diagnosis and/or treatment.
To confirm that the patient's population was not a population of difficult-to-treat patients, we would like to mention that after one-year of follow-up on the improved therapy (mostly on CBZ or VPA) more then 60% epilepsy patients were seizure-free.
As mentioned no special selection was done; only patients with another progressive neurological or psychiatric illness, severe somatic pathology or mentally disabled were excluded from the study.
We used QOLIE-31 scale of quality of life 10 which is the modified version of QOLIE-89. 6 QOLIE-31 consists of 31 questions divided into 7 groups (subscales). Our group has previously done the crosscultural adaptation of this scale into the Russian language.
The method of translation and cultural adaptation, as described by Cramer et al., 7 consisted of two independent forward translations into Russian by professional translators native in Russian, then the reconciled version was developed during the meeting between the forward translation and QOL researchers. Thereafter the reconciled translation was backtranslated into English by another professional translator. After second reconciliation meeting the scale was tested in 10 patients to assess clarity, appropriateness of wording, understandability and cultural relevance of the translated version. The final step was the meeting between the translators and QOL researchers to ensure that the original questionnaire and the translations measure the same concepts. This procedure has been performed in collaboration with Dr. J. Cramer.
In the present study, we accounted the score of the each subscale and total score; higher scores indicated better quality of life. Subscales assessed such items as Seizure Worry, Overall Quality of Life (Overall QOL), Emotional Well-being, Energy/ Fatigue, Cognitive Functioning, Medication Effects and Social Functioning. The patients were divided into two groups: ''de novo'' (newly diagnosed epilepsy patient) (n = 98) and previously treated (n = 144).
We analyzed HRQOL patients with epilepsy (by QOLIE-31 questionnaire) in dependence of (1) frequency; (2) duration of disease. Depression in our patients was also assessed; it was diagnosed according to ICD-10 criteria. Beck Depression Inventory was administered. But in our study were revealed only few epilepsy patients with depression and they were excluding from following analysis. We plan more thorough studies of depression and anxiety in epilepsy patients using different scales.
Statistical analysis was done by ''SPSS for Windows'' of ''SPSS'' (1999) with processing of data by methods of variation statistics including measuring of mean scores, standard deviations and other parameters. For revealing connection between two or more quantitative factors the method of stepwise regression and R-multiple correlation coefficient were used.
Results
Two hundred and forty two patients were investigated (Table 1) . One hundred and forty four patients (previously treated group) were with pre-existing diagnosis of epilepsy and received antiepileptic drug (AED) treatment previously initiated in other institutions. Unfortunately in the most cases these therapy regimens were suboptimal: 77 patients (53.5%) received inadequate (usually low doses) polytherapy: 56 patients (38.9%) were on 2 AED, 13 patients (9.0%)--on 3 AED, 8 patients (5.6%)--on 4 AED; 67 patients (46.5%) received inadequate monotherapy. The duration of the disease in the previously treated group was from 2 to 15 years.
Ninety-eight patients with the duration from 0.5 to 5 years in most cases were untreated. These patients were newly diagnosed in our Department (''de-novo'' group). The comparison of clinical features of these groups is shown in the Table 2 .
Twenty eight patients (11.6%) were classified as having idiopathic epilepsy, 116 (47.9%) as having cryptogenic epilepsy, 98 (40.5%) as having symptomatic epilepsy. Magnetic resonance imaging in patients with partial symptomatic epilepsy revealed various structural pathology (lobar atrophy, brain cysts, usually of post-stroke origin, low-grade glioma, in some cases-mesial temporal sclerosis, cortical displasia).
Seizures occurred several times per week in 140 (57.9%) patients, 47 (19.4%) had several seizures per month, 31 (12.8%) had 7-12 seizures per year, 13 (5.4%) had 1-2 seizures per year and 11 (4.5%) had been completely seizure-free in the previous 12-month period. Frequency of seizures was higher in the group of previously treated patients, as shown in the Table 2 . These patients had longer duration of epilepsy, and, as mentioned, they received suboptimal therapy for several years.
Mean total score of the quality of life in patients with epilepsy by QOLIE-31 scale was 42.13 AE 4.14 Table 3 . Statistically significant differences in quality of life (assessed by subscales) were only in Emotional Well-Being and Cognitive functioning subscales but these differences were minimal from the clinical point of view. The comparison of patients on suboptimal mono and polytherapy has been performed, but there was no significant difference for QOL (Table 4) .
We analyzed relationship between quality of life (total score) and frequency of seizures and duration of disease in all patients. We revealed that frequency of seizures was the most significant parameter related to QOL (R = 0.46). Duration of disease also correlated with QOL score (R = 0.24) (all correlations are negative and highly significant with p < 0.001).
Also significant but rather weak association between frequency of seizures and subscales of quality of life (with the exception of Emotional Well-being subscale) in all patients was noticed ( Table 5) . Duration of epilepsy correlated with less number of subscales: Energy/fatigue, Medication effects, Social functioning, Overall QOL subscales.
We separately investigated factors influencing on HRQOL in the group of patients with epilepsy ''de novo''. The results were further compared with those in the group of previously treated patients.
The most relevant factor for QOL in previously untreated patients was also frequency of seizures (R = 0.42 with total score, p < 0.001). There was weaker correlation between frequency of seizures and score of Social functioning subscale (R = 0.37, p < 0.001). Duration of disease was not significantly associated with the total score of HRQOL in this group.
In the group of previously treated patients frequency of seizures influenced on QOL (R = 0.48 with total score, p < 0.001). Correlations between duration of disease and total score of HRQOL were insignificant. In the group of previously treated patients the significant but rather weak influence of frequency of seizures on quality of life was noticed by the following subscales: Energy/Fatigue, Medication Effects, Emotional Well-being, Social Functioning (Table 6 ). We did not reveal any significant correlation between frequency of seizures Factors influencing on quality of life in people with epilepsy 131 
Discussion
Epilepsy is one of the most common and challenging neurologic disorders. The main disturbances, seizures, in patients with epilepsy appear episodically but they are so substantial for patients and often absolutely change the whole lifestyle that assessment of quality of life of patients with epilepsy is really important. Need of investigation of influence of epilepsy on psychosocial aspect of life of patients is apparent. 1, 18, 20 Optimal quality of life is one of the main goals of antiepileptic therapy. 9 Improving health-related quality of life (HRQOL) was recognized as an essential component of management of patients with epilepsy. 21 Previous studies of QOL in people with epilepsy, performed mostly in Western Europe and North America, have highlighted diminished QOL. It was demonstrated that Quality of life was worse in patients with epilepsy than in the general population; it was comparable or worse in patients with epilepsy than that in patients with other chronic conditions; and it was similar to that of healthy persons in patients with well-controlled epilepsy. 2, 30 Up to now there are no published in the English literature data concerning the QOL in people with epilepsy in Russia. The present study was focused on investigation of QOL of patients with epilepsy in Russia and comparison of the most important clinical factors influencing on quality of life in newly diagnosed and previously treated epilepsy patients.
According to Cramer et al. 6 usually the total QOL-31 score in epilepsy patients varied from 40 to 60 points. In our patients the total score of QOL was rather low--42.13 AE 4.14.
Studies revealed that the most important for patients with epilepsy were social and psychological aspects of daily life: frequency of seizures, effect of antiepileptic drugs. 8, 23, 25 Frequency of seizures was described as one of the most relevant determinants of poor QOL scores. 17, 27 We revealed that the following significant factors influenced on HRQOL of our patients: frequency of seizures and duration of disease. The most important parameter determining quality of life was the frequency of seizures. Duration of the disease lesser influenced on the HRQOL.
We demonstrated that frequency of seizures was the significant predictor of QOL in both groups: previously suboptimally treated (without significant difference on mono and polytherapy) and newly diagnosed. In both groups of our patients seizure frequency was substantial, though higher in previously treated patients. Long history of suboptimally treated epilepsy might have contributed to high seizure frequency in this group. It is important to mention that many untreated patients also had rather long duration of epilepsy, as demonstrated in the Table 2 , that could explain frequent seizures in this group of patients also. These findings demonstrate that there is a substantial need for improvement of the system of epilepsy care (both in the field of diagnosis and proper treatment) in the country.
People with epilepsy frequently report diminished socialization, negative self image, feeling of stigmatization, reduced earnings potential, and diminished hope and ambition. 11, 15 We revealed significant but rather weak dependence between frequency of seizures and subscales of quality of life: Seizure worry, Overall QOL, Energy/fatigue, Cognitive functioning, Medication effects, Social functioning. High seizure frequency limits usual daily activity and leads to impairment of physical, social and emotional functioning and finally to general deterioration of one's quality of life. Social functioning could be the most vulnerable parameter as in newly diagnosed patients with epilepsy frequency of seizures influenced only on social functioning subscale.
In the group of previously treated patients the correlation between frequency of seizures and Social Functioning and Emotional Well-Being subscales were the most relevant and also indicating the significance of social activity for the person with epilepsy. Though attitudes toward people with epilepsy have improved over the years for many people with epilepsy stigma continues to adversely impact their psychological wellbeing and quality of life. It is the true for Russia as well as for many other countries. Stigma can be one of the most distressing consequences of having seizures. Neither informal stigma nor formal discrimination is inevitable for epilepsy patients; however, for many individuals, 132
A.B. Guekht et al. epilepsy remains a defining feature of their identity and such issues are a source of considerable concern for a number of patients. 14 
Conclusions
In epilepsy patients in Russia the total score of QOLIE-31 was rather low--42.13 AE 4.14 (compared to data from the USA). 6 Frequency of seizures was the most important factor influencing QOL in patients with epilepsy (newly diagnosed and previously treated).
